UC SAN FRANCISCO and Berkeley Lights Inc. formed a collaboration that gives UCSF researchers access to Berkeley Lights’ opto-nanofluidic biosystems, including single-cell genomic profiling of pre-annotated tissue samples, the development of precision diagnostics, and point-of-care therapies. Through the collaboration, UCSF researchers will study various cancer types to better understand the characterization and functionality of cell...
How’s this for a paradox: The better cancer centers become at keeping patients alive, the more expensive cancer care becomes. This brutal tradeoff hits harder in rural areas, where the cancer burden is higher and the investigator and clinical trial representation is lower.
